Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.

about

Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases [Pharmacological treatment of motor symptoms in Parkinson's diseases].Association of Parkinson Disease Induction with Cardiac Upregulation of Apoptotic Mediators P53 and Active Caspase-3: An Immunohistochemistry Study

P2860

Q28066691-1E4CC595-7108-46FE-B296-242FD5F783B7 Q52703430-409B6041-A9B9-4D2D-A6DF-6983D85B4D4A Q58712148-331C83AC-1C41-4C31-B69D-89AD5EC06D48

P2860

Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.

Item

http://www.wikidata.org/entity/Q38877254

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.

@en

type

Item

label

Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.

@en

prefLabel

Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.

@en

P1476

Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.

@en

P2093

Santiago Perez-Lloret

http://www.w3.org/2001/XMLSchema#string

P2860

Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes

Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease

Piribedil-induced sleep attacks in patients without Parkinson disease: a case series

Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease

Effects of the dopamine agonist piribedil on prefrontal temporal cortical network function in normal aging as assessed by verbal fluency

Cognitive skill learning in healthy older adults after 2 months of double-blind treatment with piribedil

Impulse control disorder and piribedil: report of 5 cases

P2888

s40263-016-0360-5

P304

703-717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40263-016-0360-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Rascol

P577

2016-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27344665

http://www.w3.org/2001/XMLSchema#string

Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.

about

P2860

P2860

Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698